Evidence map›Paper›PMID 25225343›Full record

ArticleAntimicrobial agents and chemotherapy2014

Reply to "compliance with antimicrobial therapy for buruli ulcer".

Richard O Phillips, Fred S Sarfo, Mohammed K Abass, Michael Frimpong, Edwin Ampadu, Mark Forson, Yaw A Amoako, William Thompson, Kingsley Asiedu, Mark Wansbrough-Jones

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Buruli ulcer.Nature reviews. Disease primers · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Richard O PhillipsKomfo Anokye Teaching Hospital (KATH), Kumasi, Ghana Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana rodamephillips@gmail.com.
Fred S SarfoKomfo Anokye Teaching Hospital (KATH), Kumasi, Ghana.
Mohammed K AbassAgogo Presbyterian Hospital, Agogo, Ghana.
Michael FrimpongKwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
Edwin AmpaduNational Buruli Ulcer Control Programme, Accra, Ghana.
Mark ForsonTepa Government Hospital, Tepa, Ghana.
Yaw A AmoakoKomfo Anokye Teaching Hospital (KATH), Kumasi, Ghana.
William ThompsonAgogo Presbyterian Hospital, Agogo, Ghana.
Kingsley AsieduGlobal Buruli Ulcer Initiative, World Health Organization, Geneva, Switzerland.
Mark Wansbrough-JonesSt. George's University of London, London, United Kingdom.
Komfo Anokye Teaching Hospital · GHPresbyterian University, Ghana · GHGhana Education Service · GHKwame Nkrumah University of Science and Technology · GHSt George's, University of London · GBWorld Health Organization · CH

Funding

Medical Research Council MR/J01477X/1World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBuruli UlcerClarithromycinFemaleHumansMycobacterium ulceransRifampinStreptomycinAnti-Bacterial AgentsClarithromycinRifampinStreptomycin

Identifiers

PMID25225343
PMCPMC4187934
OpenAlexW2143782843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.